The global active pharmaceutical ingredients market size was estimated at USD 255.01 billion in 2024 and is projected to grow at a CAGR of 5.85% from 2025 to 2030. The market is driven by several key factors. The growing global demand for pharmaceutical drugs, particularly in emerging ma... Read More »
December 2024The global lysosomal acid lipase deficiency treatment market size was estimated at USD 196.63 billion in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030. A significant increase in diagnosed cases of lysosomal acid lipase deficiency (LAL-D), a rare genetic disorder, is e... Read More »
December 2024The global hair growth supplements market size was estimated at USD 830.6 million in 2024 and is expected to grow at a CAGR of 15.5% from 2025 to 2030. The growth of the hair growth supplements industry can be attributed to the shift from pharmaceuticals to nutraceuticals owing to higher... Read More »
December 2024The global omega 3 prescription drugs market size was estimated at USD 1.35 billion in 2024 and is expected to expand at a CAGR of 4.90% by 2030. The market is driven by rising cases of cardiovascular diseases and the increasing use of these formulations to manage hypertriglyceridemia. E... Read More »
December 2024The global rare disease treatment market size was estimated at USD 195.2 billion in 2024 and is anticipated to expand at a CAGR of 11.6% by 2030. The presence of a strong product pipeline and their expected launches are expected to drive market growth. For instance, in October 2024, FDA ... Read More »
December 2024The global medical foods market size was valued at USD 23.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.1% 2024 to 2030. The market growth is driven by the rising prevalence of chronic diseases like Alzheimer's, ADHD, osteoporosis, osteoarthritis... Read More »
December 2024The India nutritional supplements market size was estimated at USD 42.97 billion in 2024 and is expected to grow at a CAGR of 8.1% from 2025 to 2030. India’s nutritional supplements market is primarily driven by its young population, increasing disposable incomes, and rising health... Read More »
December 2024The Asia Pacific multi cancer early detection market size was estimated at USD 249.62 million in 2024 and is projected to grow at a CAGR of 17.76% from 2025 to 2030. The market growth is attributed to the growing healthcare reforms, improvement in infrastructure, a rising prevalence of c... Read More »
December 2024The Europe nutrition and supplements market size was estimated at USD 87.33 billion in 2024 and is expected to grow at a CAGR of 6.1% from 2025 to 2030. This growth is driven by increasing consumer health and wellness awareness, rising disposable incomes, and a growing preference for pre... Read More »
November 2024The global kidney cancer drugs market size was valued at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2030. This growth is attributed to the advancements in treatment options, rising healthcare expenditure, and increasing research and development effor... Read More »
November 2024The Asia Pacific nutritional supplements market size was valued at USD 192.44 billion in 2024 and is expected to grow at a CAGR of 6.71% from 2025 to 2030. Asia Pacific has been one of the forerunners in the nutritional supplements industry. The population across the sub-continent has be... Read More »
November 2024The global nutritional supplements market size was estimated at USD 485.62 billion in 2024 and is expected to grow at a CAGR of 6.42% from 2025 to 2030. The increasing focus on health has greatly contributed to the market's growth. In addition, the rising rates of non-communicable diseas... Read More »
November 2024The global metabolic disorder therapeutics market size was estimated at USD 77.24 billion in 2024 and is projected to grow at a CAGR of 7.8% from 2025 to 2030. In Europe, reports indicate that approximately 25% of adults are afflicted by metabolic syndrome, a statistic mirrored in Brazil... Read More »
November 2024The global tumor necrosis factor inhibitor drugs market size was valued at USD 24.9 billion in 2024 and is anticipated to grow at a CAGR of 2.2% from 2025 to 2030. The market growth is attributed to the increasing occurrence of autoimmune diseases, continuous development of novel TNF inh... Read More »
November 2024The global burn ointment market size was estimated at USD 1.08 billion in 2024 and is projected to grow at a CAGR of 6.1% from 2025 to 2030. The increasing prevalence of burn injuries worldwide can drive this growth. Accidental burns, industrial accidents, and household incidents contrib... Read More »
November 2024The global women’s health market size was estimated at USD 49.33 billion in 2024 and is expected to grow at a CAGR of 5.1% from 2025 to 2030. Market growth can be attributed to the increase in the geriatric population of women and the introduction of new advanced therapeutic produc... Read More »
November 2024The global dry eye syndrome treatment market size was estimated at USD 6.29 billion in 2024 and is anticipated to expand at a CAGR of 6.56% by 2030. The dry eye syndrome treatment market is witnessing growth due to factors such as rising incidences of dry eye syndrome due to increased sc... Read More »
November 2024The global non-steroidal anti-inflammatory drugs market size was estimated at USD 22.58 billion in 2024 and is expected to grow at a CAGR of 5.66% from 2025 to 2030. The growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market is driven by the global rise in chronic pain preva... Read More »
November 2024The U.S. women’s health market size was estimated at USD 18.82 billion in 2024 and is expected to grow at a CAGR of 3.7% from 2025 to 2030. Market growth can be attributed to the rising prevalence of target diseases such as menopause, hormonal infertility, endometriosis, child or e... Read More »
November 2024The global non-opioid pain treatment market size was estimated at USD 45.32 billion in 2024 and is projected to grow at a CAGR of 7.69% from 2025 to 2030. The rise in R&D investments by leading companies to develop innovative non-opioid pain relief drugs, along with supportive initia... Read More »
November 2024